Cargando…
Adiponectin: friend or foe in obesity and inflammation
Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, d...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388816/ https://www.ncbi.nlm.nih.gov/pubmed/37724325 http://dx.doi.org/10.1515/mr-2022-0002 |
_version_ | 1785082203904933888 |
---|---|
author | Luo, Liping Liu, Meilian |
author_facet | Luo, Liping Liu, Meilian |
author_sort | Luo, Liping |
collection | PubMed |
description | Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, diabetes, and cardiovascular diseases. However, while the insulin-sensitizing and cardioprotective effects of adiponectin have been widely appreciated in the field, the obesogenic and anti-inflammatory effects of adiponectin are still of much debate. Understanding the physiological function of adiponectin is critical for adiponectin-based therapeutics for the treatment of metabolic diseases. |
format | Online Article Text |
id | pubmed-10388816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-103888162023-09-18 Adiponectin: friend or foe in obesity and inflammation Luo, Liping Liu, Meilian Med Rev (Berl) Review Adiponectin is an adipokine predominantly produced by fat cells, circulates and exerts insulin-sensitizing, cardioprotective and anti-inflammatory effects. Dysregulation of adiponectin and/or adiponectin signaling is implicated in a number of metabolic diseases such as obesity, insulin resistance, diabetes, and cardiovascular diseases. However, while the insulin-sensitizing and cardioprotective effects of adiponectin have been widely appreciated in the field, the obesogenic and anti-inflammatory effects of adiponectin are still of much debate. Understanding the physiological function of adiponectin is critical for adiponectin-based therapeutics for the treatment of metabolic diseases. De Gruyter 2022-07-01 /pmc/articles/PMC10388816/ /pubmed/37724325 http://dx.doi.org/10.1515/mr-2022-0002 Text en © 2022 the author(s), published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Review Luo, Liping Liu, Meilian Adiponectin: friend or foe in obesity and inflammation |
title | Adiponectin: friend or foe in obesity and inflammation |
title_full | Adiponectin: friend or foe in obesity and inflammation |
title_fullStr | Adiponectin: friend or foe in obesity and inflammation |
title_full_unstemmed | Adiponectin: friend or foe in obesity and inflammation |
title_short | Adiponectin: friend or foe in obesity and inflammation |
title_sort | adiponectin: friend or foe in obesity and inflammation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388816/ https://www.ncbi.nlm.nih.gov/pubmed/37724325 http://dx.doi.org/10.1515/mr-2022-0002 |
work_keys_str_mv | AT luoliping adiponectinfriendorfoeinobesityandinflammation AT liumeilian adiponectinfriendorfoeinobesityandinflammation |